CorMedix, a biopharmaceutical company specialising in critical care products, is to acquire Melinta Therapeutics for $300m.

Eli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo Nordisk.

Bayer disclosed that its Q2 earnings were inflated by transfer fees at its German football club Bayer Leverkusen.

The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes.

Astria has made an exclusive licensing agreement with Kaken for the development and commercialisation rights of navenibart in Japan.

Primary packaging is never an afterthought in the world of injectable drugs, where systems such as vials, syringes, and ...